MEDIROM Healthcare Technologies(MRM)

搜索文档
MEDIROM Healthcare Technologies Inc. Regains Compliance with NASDAQ Continued Listing Requirements
Globenewswire· 2025-06-06 02:02
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (“MEDIROM” or the “Company”), today announced that on June 4, 2025, it received a written notification from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with Nasdaq’s minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). On February 27, 2025, the Company received notice from Nasdaq that it was not in compl ...
Specific Health Guidance Service Utilizing the "Lav" Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals!
GlobeNewswire News Room· 2025-05-30 21:00
TOKYO, May 30, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ("MEDIROM," "we,” “us” or “our”), a holistic healthcare company based in Japan, announces that its subsidiary, MEDIROM MOTHER Labs, Inc., has surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals in its specific health guidance service utilizing the healthcare app "Lav." This service started in 2019 and provides efficient and continuous health support utilizing information and comm ...
MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and 20% Improvement in Earnings for 2024; Webcast to Discuss Financial Results to be held on May 21st, 2025 at 8:30 AM ET
Globenewswire· 2025-05-20 20:56
TOKYO, May 20, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”), today announced that for the year ended December 31, 2024, the Company had total revenue of $52,736,000, a 22% increase over total revenue of $43,388,000 for the year ended December 31, 2023. (The Company reports its financial results in Japanese yen and figures presented in this press release in US dollars have been translated for convenie ...
MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results
Globenewswire· 2025-05-19 20:44
TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”) today announced that it will host a webcast to review the Company’s financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company f ...
MEDIROM Healthcare Technologies(MRM) - 2024 Q4 - Annual Report
2025-04-30 04:15
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Fumitoshi Fujiwara Chief Financial Officer Telephone: +81-(0)3-6721-7364 Email: ir@medirom.co.jp 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan (Name, Telephone, E-mail and/or Facsimile Number and Address of Company Contact Pe ...
MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (Approximately $2.4 Million*) Unsecured Loan Financing
Newsfilter· 2025-03-18 05:30
文章核心观点 - 日本综合医疗保健公司MEDIROM获得3.5亿日元(约240万美元)无抵押短期银行贷款 用于偿还子公司债务和一般营运资金 助力Mother Bracelet开发 [1][2] 公司业务情况 - 截至2025年1月31日 公司在日本经营308家休闲沙龙 主打品牌为Re.Ra.Ku® 提供医疗保健服务 [5] - 2015年公司进入健康科技业务 推出使用自研按需培训应用Lav®的新医疗保健计划 [5] - 2020年公司进入设备业务 开发了智能追踪器MOTHER Bracelet® [5] - 2023年公司推出面向企业客户的远程监控系统REMONY 已收到护理、交通、建筑和制造等行业订单 [5] - 公司希望通过多样化的健康相关产品和服务收集和管理用户医疗数据 成为医疗行业大数据领域的领导者 [5] 贷款情况 - 公司获得3.5亿日元(约240万美元)无抵押短期银行贷款 年利率1.875% [1] - 公司已使用2亿日元贷款资金偿还子公司MEDIROM Mother Labs Inc.的债务 该子公司也是新贷款的担保人 [1] - 公司打算将剩余贷款资金用于一般营运资金 包括Mother Bracelet开发 [1] 管理层观点 - 公司首席执行官Koji Eguchi表示 新的贷款融资加强了公司财务状况 为开发Mother Bracelet提供额外支持 [2]
MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (Approximately $2.4 Million*) Unsecured Loan Financing
Globenewswire· 2025-03-18 05:30
文章核心观点 - 公司获得3.5亿日元(约240万美元)无担保短期银行贷款,部分用于偿还子公司债务,其余用于一般营运资金,包括开发Mother Bracelet,CEO称贷款加强了公司财务状况 [1][2] 公司业务情况 - 公司是一家整体医疗保健公司,截至2025年1月31日在日本经营308家休闲沙龙,Re.Ra.Ku®是其领先品牌 [6] - 2015年进入健康科技业务,推出使用“Lav®”按需培训应用程序的新医疗保健计划 [6] - 2020年进入设备业务,开发了智能追踪器“MOTHER Bracelet®” [6] - 2023年推出面向企业客户的远程监控系统REMONY,已收到包括护理、运输、建筑和制造等行业的订单 [6] - 公司希望通过多样化的健康相关产品和服务收集和管理用户和客户的医疗保健数据,成为医疗保健行业大数据领域的领导者 [6] 贷款情况 - 公司获得3.5亿日元(约240万美元)无担保短期银行贷款,年利率为1.875% [1] - 已使用2亿日元贷款资金偿还子公司MEDIROM Mother Labs Inc.的债务,该子公司也是新贷款的担保人 [1] - 公司打算将剩余贷款资金用于一般营运资金,包括Mother Bracelet开发 [1]
MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs' Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)
Newsfilter· 2025-03-14 05:00
TOKYO, March 13, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) (the "Company" or "MEDIROM") announces that Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc. ("Mother Labs"), a subsidiary of the Company, has made a second investment in Mother Labs' Series A financing at a pre-money valuation of JPY9 billion (as of March 13, 2025, approximately US$60 million). This new investment follows Mr. Hayami's initial investment in the Series A financing in December 2024. ...
MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs' Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)
GlobeNewswire News Room· 2025-03-14 05:00
文章核心观点 - 公司子公司MEDIROM Mother Labs Inc.首席商务官Yasuhiro Hayami对该子公司A轮融资进行第二次投资,公司子公司专注健康科技领域 [1][6] 高管背景 - Yasuhiro Hayami为MEDIROM MOTHER Labs Inc.首席商务官 [2] - 其职业经历丰富,2024年被任命为MEDIROM Rehab Solutions, Inc.董事长及MEDIROM MOTHER Labs首席商务官 [6] 公司情况 - MEDIROM Healthcare Technologies Inc.旗下子公司Mother Labs专注健康科技领域,核心业务包括通过“Lav”健康应用提供“特定健康指导计划”以及开发销售24/7免充电MOTHER Bracelet智能追踪器 [6][7] - MOTHER Bracelet是全球首款24/7免充电智能追踪器,采用硅谷科技公司创新技术,基于身体与周围空气温差发电,可记录五项基本指标 [8] 投资情况 - Yasuhiro Hayami以90亿日元(截至2025年3月13日约6000万美元)的投前估值对Mother Labs的A轮融资进行第二次投资,其曾于2024年12月进行首次投资 [1]
MEDIROM Healthcare Technologies Inc. Announces Preliminary, Unaudited Financial Results for Full Year 2024 Under Japanese GAAP
Globenewswire· 2025-02-18 22:00
文章核心观点 日本综合医疗保健公司MEDIROM公布2024年初步财务结果,显示营收增长和调整后营业利润改善,公司正与审计机构合作完成美国公认会计准则下的审计,并希望在2025年延续增长势头 [1][12] 分组1:财务结果概述 - 2024年未经审计的初步总营收约82亿日元(5260万美元),较2023年增加约14亿日元(920万美元),主要因沙龙销售、外包收入及康复业务收入增加 [5] - 2024年未经审计的初步调整后营业费用约81.2亿日元(5160万美元),较2023年增加约9亿日元(570万美元),主要因沙龙销售成本、运营成本和专业费用增加 [5] - 2024年未经审计的初步调整后营业利润约1.6亿日元(100万美元),较2023年营业亏损增加约5.52亿日元(350万美元),主要因营收增长超过营业费用增长 [5] 分组2:关键绩效指标 - 2024年12月沙龙总数为308家,有数据的沙龙为283家 [10] - 2024年服务总客户数为945395人 [10] - 2024年每位客户平均销售额为7111日元(45.2美元) [10] - 2024年平均回头率为76.3% [10] - 2024年平均运营比率为45.7% [10] 分组3:管理层讨论 - 公司CEO对2024年营收增长和调整后营业利润改善表示满意,直营和加盟沙龙互补,康复业务也有贡献,公司团队达成目标,将努力完成审计并在2025年延续增长 [12] 分组4:公司概况 - 公司运营308家放松沙龙,Re.Ra.Ku是领先品牌,提供医疗保健服务 [20] - 2015年进入健康科技业务,推出“Lav”应用程序;2020年进入设备业务,开发“MOTHER Bracelet”;2023年推出REMONY远程监控系统 [20] - 公司希望通过多元化产品和服务收集管理医疗数据,成为医疗行业大数据领导者 [20]